Measurement of binding kinetics using quantum plasmonic resonance sensing applied to HIV-1
K.T. Mpofu, C. Lee, G.E.M. Maguire, H.G. Kruger, M.S. Tame

TL;DR
This paper demonstrates theoretically that quantum states of light, especially Fock states, enhance the precision of measuring HIV-1 binding kinetics using quantum plasmonic resonance sensing, potentially aiding drug discovery and virus research.
Contribution
It introduces a quantum sensing approach using Fock states to improve the accuracy of binding kinetics measurements for HIV-1, advancing quantum bio-sensing applications.
Findings
Fock states improve measurement precision over classical states.
Quantum sensing can detect small signals buried in noise.
Potential applications in HIV drug discovery and virus research.
Abstract
The work done in this paper is an extension of the work done by Mpofu et al in [1]. The motivation for this paper is to show the potential of quantum bio-sensing techniques in applications to complex viruses like the human immunodeficiency virus (HIV) and to show it's potential in binding reactions where the signal is small and can potentially be buried in noise. In this paper we show theoretically that using quantum states of light such as the Fock state improves the precision in the estimation of kinetic parameters measured from the sensorgrams produced by the Kretschmann conguration. Though the Fock state is not the only quantum state in this study we look only at the Fock state because it has been shown to be the state which offers the best enhancement [1]. We show here that the Fock state allows us to measure the parameters more accurately in comparison to the classical (Coherent)…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHIV Research and Treatment · Monoclonal and Polyclonal Antibodies Research · HIV/AIDS drug development and treatment
